Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Mack, H. Witt, R. Piro, L. Gu, S. Zuyderduyn, A. Stütz, X. Wang, M. Gallo, L. Garzia, K. Zayne, X. Zhang, V. Ramaswamy, N. Jäger, D. Jones, M. Sill, Trevor Pugh, M. Ryzhova, K. Wani, D. Shih, R. Head, M. Remke, S. Bailey, T. Zichner, C. Faria, M. Barszczyk, S. Stark, H. Şeker-Cin, S. Hutter, P. Johann, S. Bender, V. Hovestadt, T. Tzaridis, A. Dubuc, P. Northcott, J. Peacock, K. Bertrand, S. Agnihotri, F. Cavalli, I. Clarke, K. Nethery-Brokx, C. Creasy, S. Verma, J. Koster, X. Wu, Y. Yao, T. Milde, P. Sin‐Chan, J. Zuccaro, L. Lau, S. Pereira, P. Castelo-Branco, M. Hirst, M. Marra, S. Roberts, D. Fults, L. Massimi, Y. Cho, T. Meter, W. Grajkowska, B. Lach, A. Kulozik, A. Deimling, O. Witt, S. Scherer, X. Fan, K. Muraszko, M. Kool, S. Pomeroy, N. Gupta, J. Phillips, A. Huang, U. Tabori, C. Hawkins, D. Malkin, P. Kongkham, W. Weiss, N. Jabado, J. Rutka, E. Bouffet, J. Korbel, M. Lupien, K. Aldape, Gary Bader, R. Eils, P. Lichter, P. Dirks, S. Pfister, A. Korshunov, M. Taylor (2014)
Epigenomic alterations define lethal CIMP-positive ependymomas of infancyNature, 506
D. Brat, R. Verhaak, K. Aldape, W. Yung, S. Salama, L. Cooper, Esther Rheinbay, C. Miller, M. Vitucci, O. Morozova, A. Robertson, H. Noushmehr, P. Laird, A. Cherniack, R. Akbani, J. Huse, G. Ciriello, L. Poisson, J. Barnholtz-Sloan, M. Berger, C. Brennan, R. Colen, H. Colman, A. Flanders, C. Giannini, Mia Grifford, A. Iavarone, R. Jain, I. Joseph, Jaegil Kim, K. Kasaian, T. Mikkelsen, Bradley Murray, B. O'neill, L. Pachter, D. Parsons, C. Sougnez, E. Sulman, S. Vandenberg, Erwin Meir, A. Deimling, Hailei Zhang, D. Crain, Kevin Lau, D. Mallery, S. Morris, J. Paulauskis, R. Penny, T. Shelton, M. Sherman, P. Yena, Aaron Black, Jay Bowen, Katie Dicostanzo, J. Gastier-Foster, K. Leraas, T. Lichtenberg, C. Pierson, N. Ramirez, Cynthia Taylor, Stephanie Weaver, L. Wise, E. Zmuda, Tanja Davidsen, John Demchok, G. Eley, M. Ferguson, C. Hutter, Kenna Shaw, B. Ozenberger, Margi Sheth, H. Sofia, R. Tarnuzzer, Zhining Wang, Liming Yang, J. Zenklusen, Brenda Ayala, J. Baboud, Sudha Chudamani, M. Jensen, Jia Liu, T. Pihl, R. Raman, Yunhu Wan, Ye Wu, Adrian Ally, J. Auman, M. Balasundaram, S. Balu, S. Baylin, R. Beroukhim, M. Bootwalla, R. Bowlby, C. Bristow, Denise Brooks, Y. Butterfield, R. Carlsen, S. Carter, L. Chin, Andy Chu, E. Chuah, K. Cibulskis, A. Clarke, Simon Coetzee, Noreen Dhalla, T. Fennell, Sheila Fisher, S. Gabriel, G. Getz, R. Gibbs, R. Guin, Angela Hadjipanayis, D. Hayes, T. Hinoue, K. Hoadley, R. Holt, A. Hoyle, S. Jefferys, Steven Jones, Corbin Jones, R. Kucherlapati, Phillip Lai, E. Lander, Semin Lee, Lee Lichtenstein, Yussanne Ma, D. Maglinte, Harshad Mahadeshwar, M. Marra, Michael Mayo, S. Meng, M. Meyerson, P. Mieczkowski, Richard Moore, Lisle Mose, A. Mungall, A. Pantazi, Michael Parfenov, P. Park, J. Parker, C. Perou, A. Protopopov, X. Ren, J. Roach, Thaís Sabedot, J. Schein, S. Schumacher, J. Seidman, S. Seth, Hui Shen, J. Simons, Payal Sipahimalani, Matthew Soloway, Xingzhi Song, Huandong Sun, B. Tabak, Angela Tam, Donghui Tan, Jiabin Tang, N. Thiessen, T. Triche, D. Berg, Umadevi Veluvolu, S. Waring, D. Weisenberger, M. Wilkerson, Tina Wong, Junyuan Wu, Liu Xi, A. Xu, Lixing Yang, Travis Zack, Jianhua Zhang, B. Aksoy, H. Arachchi, C. Benz, Brady Bernard, Daniel Carlin, Juok Cho, D. Dicara, S. Frazer, G. Fuller, Jianjiong Gao, N. Gehlenborg, D. Haussler, David Heiman, L. Iype, A. Jacobsen, Z. Ju, Sol Katzman, Hoon Kim, T. Knijnenburg, R. Kreisberg, M. Lawrence, William Lee, Kalle Leinonen, Pei Lin, Shiyun Ling, Wenbin Liu, Yingchun Liu, Yuexin Liu, Yiling Lu, G. Mills, S. Ng, M. Noble, Evan Paull, A. Rao, Sheila Reynolds, G. Saksena, Zachary Sanborn, C. Sander, N. Schultz, Y. Şenbabaoğlu, R. Shen, I. Shmulevich, Rileen Sinha, Josh Stuart, S. Sumer, Yichao Sun, Natalie Tasman, B. Taylor, Douglas Voet, Nils Weinhold, J. Weinstein, Da Yang, K. Yoshihara, Siyuan Zheng, Wei Zhang, L. Zou, T. Abel, S. Sadeghi, M. Cohen, J. Eschbacher, E. Hattab, A. Raghunathan, M. Schniederjan, Dina Aziz, G. Barnett, Wendi Barrett, D. Bigner, L. Boice, C. Brewer, C. Calatozzolo, B. Campos, C. Carlotti, T. Chan, L. Cuppini, Erin Curley, S. Cuzzubbo, K. Devine, F. DiMeco, R. Duell, J. Elder, Ashley Fehrenbach, G. Finocchiaro, W. Friedman, J. Fulop, J. Gardner, Beth Hermes, C. Herold‐Mende, C. Jungk, A. Kendler, N. Lehman, E. Lipp, Ouida Liu, Randy Mandt, Mary McGraw, R. McLendon, C. McPherson, L. Neder, P. Nguyen, Ardene Noss, R. Nunziata, Q. Ostrom, C. Palmer, A. Perin, B. Pollo, A. Potapov, O. Potapova, W. Rathmell, D. Rotin, L. Scarpace, C. Schilero, Kelly Senecal, K. Shimmel, V. Shurkhay, Suzanne Sifri, Rosy Singh, A. Sloan, Kathy Smolenski, S. Staugaitis, Ruth Steele, L. Thorne, D. Tirapelli, A. Unterberg, Mahitha Vallurupalli, Yun Wang, R. Warnick, Felicia Williams, Yingli Wolinsky, Sue Bell, Mara Rosenberg, C. Stewart, F. Huang, J. Grimsby, Amie Radenbaugh, Jianan Zhang (2015)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.The New England journal of medicine, 372 26
D. Castel, C. Philippe, R. Calmon, L. Dret, Nathalène Truffaux, N. Boddaert, M. Pages, Kathryn Taylor, P. Saulnier, L. Lacroix, A. Mackay, Chris Jones, C. Sainte‐Rose, T. Blauwblomme, F. Andreiuolo, S. Puget, J. Grill, P. Varlet, Marie-Anne Debily (2015)
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypesActa Neuropathologica, 130
J. Kwiatkowska, J. Wigowska-Sowińska, D. Napierała, R. Słomski, D. Kwiatkowski (1999)
Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis.The New England journal of medicine, 340 9
R. McLendon, A. Friedman, D. Bigner, Erwin Meir, D. Brat, Gena Mastrogianakis, J. Olson, T. Mikkelsen, N. Lehman, K. Aldape, W. Yung, O. Bogler, J. Weinstein, S. Vandenberg, M. Berger, M. Prados, D. Muzny, M. Morgan, S. Scherer, A. Sabo, L. Nazareth, L. Lewis, O. Hall, Yiming Zhu, Yanru Ren, Omar Alvi, Jiqiang Yao, A. Hawes, S. Jhangiani, G. Fowler, A. Lucas, C. Kovar, Andrew Cree, H. Dinh, J. Santibanez, Vandita Joshi, M. Gonzalez-Garay, Christopher Miller, A. Milosavljevic, L. Donehower, D. Wheeler, R. Gibbs, K. Cibulskis, C. Sougnez, T. Fennell, Scott Mahan, Jane Wilkinson, L. Ziaugra, R. Onofrio, Toby Bloom, R. Nicol, K. Ardlie, J. Baldwin, S. Gabriel, E. Lander, L. Ding, R. Fulton, M. McLellan, J. Wallis, D. Larson, Xiaoqi Shi, R. Abbott, L. Fulton, Ken Chen, D. Koboldt, M. Wendl, R. Meyer, Yuzhu Tang, Ling Lin, John Osborne, Brian Dunford-Shore, T. Miner, K. Delehaunty, C. Markovic, Gary Swift, W. Courtney, C. Pohl, S. Abbott, Amy Hawkins, Shin Leong, C. Haipek, Heather Schmidt, M. Wiechert, T. Vickery, S. Scott, D. Dooling, A. Chinwalla, G. Weinstock, E. Mardis, R. Wilson, G. Getz, W. Winckler, R. Verhaak, M. Lawrence, Michael O’Kelly, James Robinson, Gabriele Alexe, R. Beroukhim, S. Carter, Derek Chiang, Josh Gould, Supriya Gupta, Joshua Korn, C. Mermel, J. Mesirov, S. Monti, Huy Nguyen, Melissa Parkin, Michael Reich, Nicolas Stransky, B. Weir, L. Garraway, T. Golub, M. Meyerson, L. Chin, A. Protopopov, Jianhua Zhang, I. Perna, S. Aronson, N. Sathiamoorthy, Georgi Ren, Jun Yao, W. Wiedemeyer, Hyun Kim, Won Sek, Yonghong Xiao, I. Kohane, J. Seidman, P. Park, R. Kucherlapati, P. Laird, L. Cope, J. Herman, D. Weisenberger, F. Pan, D. Berg, L. Neste, Mingyu Joo, Kornel Schuebel, S. Baylin, D. Absher, Jun Li, Audrey Southwick, Shannon Brady, A. Aggarwal, Tisha Chung, G. Sherlock, J. Brooks, R. Myers, P. Spellman, E. Purdom, L. Jakkula, A. Lapuk, H. Marr, S. Dorton, Gi Yoon, Ju Han, A. Ray, V. Wang, S. Durinck, M. Robinson, Nicholas Wang, K. Vranizan, V. Peng, E. Name, G. Fontenay, J. Ngai, J. Conboy, B. Parvin, H. Feiler, T. Speed, J. Gray, C. Brennan, N. Socci, A. Olshen, B. Taylor, A. Lash, N. Schultz, B. Reva, Yevgeniy Antipin, Alexey Stukalov, Benjamin Gross, E. Cerami, Qingqing Wei, L. Qin, V. Seshan, Liliana Villafania, Magali Cavatore, L. Borsu, A. Viale, W. Gerald, C. Sander, M. Ladanyi, C. Perou, D. Hayes, M. Topal, K. Hoadley, Yuan Qi, S. Balu, Yan Shi, Junyuan Wu, R. Penny, M. Bittner, T. Shelton, E. Lenkiewicz, S. Morris, D. Beasley, Sheri Sanders, A. Kahn, R. Sfeir, Jessica Chen, D. Nassau, Larry Feng, E. Hickey, A. Barker, D. Gerhard, J. Vockley, C. Compton, J. Vaught, P. Fielding, M. Ferguson, C. Schaefer, Jinghui Zhang, Subha Madhavan, K. Buetow, F. Collins, P. Good, M. Guyer, B. Ozenberger, Jane Peterson, E. Thomson (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 455
William Flavahan, Y. Drier, B. Liau, Shawn Gillespie, A. Venteicher, A. Stemmer-Rachamimov, M. Suvà, B. Bernstein (2015)
Insulator dysfunction and oncogene activation in IDH mutant gliomasNature, 529
F. Sahm, D. Schrimpf, David Jones, Jochen Meyer, A. Kratz, D. Reuss, D. Capper, C. Koelsche, A. Korshunov, B. Wiestler, I. Buchhalter, T. Milde, F. Selt, D. Sturm, M. Kool, M. Hummel, M. Bewerunge-Hudler, C. Mawrin, U. Schüller, C. Jungk, A. Wick, O. Witt, M. Platten, C. Herold‐Mende, A. Unterberg, S. Pfister, W. Wick, A. Deimling (2016)
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targetsActa Neuropathologica, 131
A. Perry, P. Wesseling (2016)
Histologic classification of gliomas.Handbook of clinical neurology, 134
Gang Easto, Gang Wu, Alexander Diaz, Barbara Paugh, Sherri Rankin, B. Ju, Yongjin Li, Xiaoyan Zhu, Chunxu Qu, Xiang Chen, Junyuan Zhang, J. Easton, M. Edmonson, Xiaotu Ma, Charles Lu, Panduka Nagahawatte, Erin Hedlund, Michael Rusch, S. Pounds, T. Lin, A. Onar-Thomas, R. Huether, R. Kriwacki, Matthew Parker, P. Gupta, J. Becksfort, Lei Wei, H. Mulder, Kristy Boggs, Bhavin Vadodaria, D. Yergeau, Jake Russell, Kerri Ochoa, R. Fulton, L. Fulton, Chris Jones, F. Boop, A. Broniscer, C. Wetmore, A. Gajjar, L. Ding, E. Mardis, R. Wilson, Michael Taylor, J. Downing, D. Ellison, Jinghui Zhang, S. Baker (2014)
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade gliomaNature genetics, 46
K. Wani, T. Armstrong, E. Vera‐Bolanos, A. Raghunathan, D. Ellison, R. Gilbertson, B. Vaillant, S. Goldman, R. Packer, M. Fouladi, I. Pollack, T. Mikkelsen, M. Prados, A. Omuro, R. Soffietti, Alicia Ledoux, Charmaine Wilson, L. Long, M. Gilbert, K. Aldape, For Network (2012)
A prognostic gene expression signature in infratentorial ependymomaActa Neuropathologica, 123
Barbara Paugh, Xiaoyan Zhu, Chunxu Qu, R. Endersby, Alexander Diaz, Junyuan Zhang, D. Bax, Diana Carvalho, R. Reis, A. Onar-Thomas, A. Broniscer, C. Wetmore, Jinghui Zhang, Chris Jones, D. Ellison, S. Baker (2013)
Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas.Cancer research, 73 20
Brett Johnson, T. Mazor, C. Hong, Michael Barnes, Koki Aihara, C. McLean, S. Fouse, Shogo Yamamoto, H. Ueda, K. Tatsuno, S. Asthana, L. Jalbert, S. Nelson, A. Bollen, W. Gustafson, E. Charron, W. Weiss, I. Smirnov, Jun Song, A. Olshen, S. Cha, Yongjun Zhao, Richard Moore, A. Mungall, Steven Jones, M. Hirst, M. Marra, N. Saito, H. Aburatani, A. Mukasa, M. Berger, Susan Chang, B. Taylor, J. Costello (2014)
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent GliomaScience, 343
Patrick Killela, Christopher Pirozzi, P. Healy, Zachary Reitman, E. Lipp, A. Rasheed, Rui Yang, B. Diplas, Zhaohui Wang, P. Greer, Huishan Zhu, Catherine Wang, A. Carpenter, H. Friedman, A. Friedman, S. Keir, Jie He, Yiping He, R. McLendon, J. Herndon, Hai Yan, D. Bigner (2014)
Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomasOncotarget, 5
Hiromichi Suzuki, Kosuke Aoki, K. Chiba, Yusuke Sato, Y. Shiozawa, Y. Shiraishi, Teppei Shimamura, A. Niida, K. Motomura, F. Ohka, Takashi Yamamoto, K. Tanahashi, Melissa Ranjit, T. Wakabayashi, T. Yoshizato, K. Kataoka, Kenichi Yoshida, Y. Nagata, A. Sato-Otsubo, Hiroko Tanaka, M. Sanada, Y. Kondo, Hideo Nakamura, M. Mizoguchi, T. Abe, Y. Muragaki, R. Watanabe, I. Ito, S. Miyano, A. Natsume, S. Ogawa (2015)
Mutational landscape and clonal architecture in grade II and III gliomasNature Genetics, 47
Matthew Parker, K. Mohankumar, C. Punchihewa, R. Weinlich, J. Dalton, Yongjin Li, Ryan Lee, R. Tatevossian, T. Phoenix, R. Thiruvenkatam, Elsie White, Bo Tang, Wilda Orisme, K. Gupta, Michael Rusch, Xiang Chen, Yuxin Li, Panduka Nagahawhatte, Erin Hedlund, D. Finkelstein, Gang Wu, S. Shurtleff, J. Easton, Kristy Boggs, D. Yergeau, Bhavin Vadodaria, H. Mulder, Jared Becksford, P. Gupta, R. Huether, Jing Ma, Guangchun Song, A. Gajjar, T. Merchant, F. Boop, Amy Smith, L. Ding, Charles Lu, Kerri Ochoa, David Zhao, R. Fulton, L. Fulton, E. Mardis, R. Wilson, J. Downing, D. Green, Jinghui Zhang, D. Ellison, R. Gilbertson (2014)
C11orf95-RELA fusions drive oncogenic NF-κB signaling in ependymomaNature, 506
Amit Jain, Anubhav Amin, Punya Jain, P. Burger, G. Jallo, M. Lim, C. Bettegowda (2012)
Subependymoma: clinical features and surgical outcomesNeurological Research, 34
R. Prayson (1997)
Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 10 4
A. Korshunov, M. Ryzhova, V. Hovestadt, S. Bender, D. Sturm, D. Capper, Jochen Meyer, D. Schrimpf, M. Kool, P. Northcott, O. Zheludkova, T. Milde, O. Witt, A. Kulozik, G. Reifenberger, N. Jabado, A. Perry, P. Lichter, A. Deimling, S. Pfister, David Jones (2015)
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markersActa Neuropathologica, 129
Gang Wu, A. Broniscer, T. McEachron, Charles Lu, Barbara Paugh, J. Becksfort, Chunxu Qu, L. Ding, R. Huether, Matthew Parker, Junyuan Zhang, A. Gajjar, M. Dyer, C. Mullighan, R. Gilbertson, E. Mardis, R. Wilson, J. Downing, D. Ellison, Jinghui Zhang, S. Baker (2012)
Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem GlioblastomasNature genetics, 44
B. Kleinschmidt-DeMasters, D. Aisner, N. Foreman (2015)
BRAF VE1 Immunoreactivity Patterns in Epithelioid Glioblastomas Positive for BRAF V600E MutationThe American Journal of Surgical Pathology, 39
D. Louis, A. Perry, G. Reifenberger, A. Deimling, D. Figarella-Branger, W. Cavenee, H. Ohgaki, O. Wiestler, P. Kleihues, D. Ellison (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 131
R. Verhaak, K. Hoadley, E. Purdom, V. Wang, Y. Qi, M. Wilkerson, C. Miller, L. Ding, Todd Golub, J. Mesirov, Gabriele Alexe, M. Lawrence, Michael O’Kelly, P. Tamayo, B. Weir, S. Gabriel, W. Winckler, Supriya Gupta, L. Jakkula, H. Feiler, J. Hodgson, C. James, J. Sarkaria, C. Brennan, A. Kahn, P. Spellman, R. Wilson, T. Speed, J. Gray, M. Meyerson, G. Getz, C. Perou, D. Hayes (2010)
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.Cancer cell, 17 1
M. Heaven, D. Flint, S. Randall, A. Sosunov, L. Wilson, S. Barnes, J. Goldman, D. Muddiman, M. Brenner (2016)
Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease.Journal of proteome research, 15 7
I. Zawlik, S. Vaccarella, D. Kita, M. Mittelbronn, S. Franceschi, H. Ohgaki (2008)
Promoter Methylation and Polymorphisms of the MGMT Gene in Glioblastomas: A Population-Based StudyNeuroepidemiology, 32
H. Witt, S. Mack, M. Ryzhova, S. Bender, M. Sill, Ruth Isserlin, A. Benner, T. Hielscher, T. Milde, M. Remke, David Jones, P. Northcott, L. Garzia, K. Bertrand, A. Wittmann, Yuan Yao, S. Roberts, L. Massimi, T. Meter, W. Weiss, N. Gupta, W. Grajkowska, B. Lach, Yoon-Jae Cho, A. Deimling, A. Kulozik, O. Witt, Gary Bader, C. Hawkins, U. Tabori, A. Guha, J. Rutka, P. Lichter, A. Korshunov, Michael Taylor, S. Pfister (2011)
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.Cancer cell, 20 2
Li Chen, Z. Voronovich, Kenneth Clark, I. Hands, Jonathan Mannas, Meggen Walsh, M. Nikiforova, E. Durbin, H. Weiss, C. Horbinski (2014)
Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative glioma.Neuro-oncology, 16 11
H. Ohgaki, P. Kleihues (2012)
The Definition of Primary and Secondary GlioblastomaClinical Cancer Research, 19
D. Parsons, Siân Jones, Xiaosong Zhang, Jimmy Lin, R. Leary, P. Angenendt, P. Mankoo, H. Carter, I. Siu, G. Gallia, A. Olivi, R. McLendon, B. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D. Busam, H. Tekleab, L. Diaz, James Hartigan, Douglas Smith, R. Strausberg, S. Marie, S. Shinjo, Hai Yan, G. Riggins, D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V. Velculescu, K. Kinzler (2008)
An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 321
S. Alexandrescu, A. Korshunov, S. Lai, S. Dabiri, S. Patil, R. Li, C. Shih, J. Bonnin, J. Baker, E. Du, D. Scharnhorst, David Samuel, D. Ellison, A. Perry (2016)
Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas—Same Entity or First Cousins?Brain Pathology, 26
P. Bandopadhayay, P. Bandopadhayay, L. Ramkissoon, P. Jain, G. Bergthold, G. Bergthold, J. Wala, J. Wala, Rhamy Zeid, S. Schumacher, S. Schumacher, Laura Urbanski, Ryan O’Rourke, Ryan O’Rourke, W. Gibson, W. Gibson, K. Pelton, S. Ramkissoon, Harry Han, Yuankun Zhu, N. Choudhari, Amanda Silva, Amanda Silva, Katie Boucher, Rosemary Henn, Y. Kang, David Knoff, B. Paolella, B. Paolella, A. Gladden-Young, P. Varlet, M. Pages, Peleg Horowitz, Alexander Federation, H. Malkin, A. Tracy, Sara Seepo, M. Ducar, P. Hummelen, M. Santi, A. Buccoliero, M. Scagnet, D. Bowers, C. Giannini, S. Puget, C. Hawkins, U. Tabori, Á. Klekner, L. Bognár, P. Burger, C. Eberhart, F. Rodriguez, D. Hill, S. Mueller, D. Haas-Kogan, D. Haas-Kogan, J. Phillips, S. Santagata, C. Stiles, J. Bradner, J. Bradner, N. Jabado, A. Goren, J. Grill, A. Ligon, L. Goumnerova, A. Waanders, P. Storm, M. Kieran, K. Ligon, K. Ligon, R. Beroukhim, R. Beroukhim, A. Resnick (2016)
MYB-QKI rearrangements in Angiocentric Glioma drive tumorigenicity through a tripartite mechanismNature genetics, 48
David Jones, B. Hutter, N. Jäger, A. Korshunov, M. Kool, H. Warnatz, T. Zichner, S. Lambert, M. Ryzhova, Dong Quang, A. Fontebasso, A. Stütz, S. Hutter, Marc Zuckermann, D. Sturm, J. Gronych, Bärbel Lasitschka, Sabine Schmidt, H. Şeker-Cin, H. Witt, M. Sultan, M. Ralser, P. Northcott, V. Hovestadt, S. Bender, E. Pfaff, S. Stark, D. Faury, J. Schwartzentruber, J. Majewski, Ursula Weber, M. Zapatka, B. Raeder, M. Schlesner, C. Worth, C. Bartholomae, C. Kalle, Charles Imbusch, S. Radomski, C. Lawerenz, P. Sluis, J. Koster, R. Volckmann, R. Versteeg, H. Lehrach, C. Monoranu, B. Winkler, A. Unterberg, C. Herold‐Mende, T. Milde, A. Kulozik, M. Ebinger, M. Schuhmann, Yoon-Jae Cho, S. Pomeroy, A. Deimling, O. Witt, Michael Taylor, S. Wolf, M. Karajannis, C. Eberhart, W. Scheurlen, M. Hasselblatt, K. Ligon, M. Kieran, J. Korbel, M. Yaspo, B. Brors, J. Felsberg, G. Reifenberger, V. Collins, N. Jabado, R. Eils, P. Lichter, S. Pfister (2013)
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytomaNature Genetics, 45
S. Hake, Benjamin Garcia, E. Duncan, M. Kauer, G. Dellaire, J. Shabanowitz, D. Bazett-Jones, C. Allis, D. Hunt (2006)
Expression Patterns and Post-translational Modifications Associated with Mammalian Histone H3 Variants*Journal of Biological Chemistry, 281
I. Blümcke, S. Müller, R. Buslei, B. Riederer, O. Wiestler (2004)
Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumorsActa Neuropathologica, 108
Q. Ostrom, H. Gittleman, Peter Liao, Chaturia Rouse, Yanwen Chen, J. Dowling, Yingli Wolinsky, C. Kruchko, J. Barnholtz-Sloan (2012)
CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.Neuro-oncology, 16 Suppl 4
Michael Garcia, D. Solomon, D. Haas-Kogan (2016)
Exploiting molecular biology for diagnosis and targeted management of pediatric low-grade gliomas.Future oncology, 12 12
S. Pfister, W. Janzarik, M. Remke, Aurélie Ernst, W. Werft, N. Becker, G. Toedt, A. Wittmann, C. Kratz, H. Olbrich, R. Ahmadi, B. Thieme, S. Joos, B. Radlwimmer, A. Kulozik, T. Pietsch, C. Herold‐Mende, A. Gnekow, G. Reifenberger, A. Korshunov, W. Scheurlen, H. Omran, P. Lichter (2008)
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas.The Journal of clinical investigation, 118 5
T. Tihan, P. Fisher, J. Kepner, C. Godfraind, R. Mccomb, Patricia Goldthwaite, P. Burger (1999)
Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome.Journal of neuropathology and experimental neurology, 58 10
P. Wesseling, M. Bent, A. Perry (2015)
Oligodendroglioma: pathology, molecular mechanisms and markersActa Neuropathologica, 129
K. Pajtler, H. Witt, M. Sill, David Jones, V. Hovestadt, Fabian Kratochwil, K. Wani, R. Tatevossian, C. Punchihewa, P. Johann, J. Reimand, H. Warnatz, M. Ryzhova, S. Mack, V. Ramaswamy, D. Capper, L. Schweizer, Laura Sieber, A. Wittmann, Zhiqin Huang, P. Sluis, R. Volckmann, J. Koster, R. Versteeg, D. Fults, H. Toledano, S. Avigad, L. Hoffman, A. Donson, N. Foreman, E. Hewer, K. Zitterbart, M. Gilbert, T. Armstrong, N. Gupta, J. Allen, M. Karajannis, D. Zagzag, M. Hasselblatt, A. Kulozik, O. Witt, V. Collins, K. Hoff, S. Rutkowski, T. Pietsch, Gary Bader, M. Yaspo, A. Deimling, P. Lichter, Michael Taylor, R. Gilbertson, D. Ellison, K. Aldape, A. Korshunov, M. Kool, S. Pfister (2015)
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.Cancer cell, 27 5
G. Schindler, D. Capper, Jochen Meyer, W. Janzarik, H. Omran, C. Herold‐Mende, K. Schmieder, P. Wesseling, C. Mawrin, M. Hasselblatt, D. Louis, A. Korshunov, S. Pfister, C. Hartmann, W. Paulus, G. Reifenberger, A. Deimling (2011)
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytomaActa Neuropathologica, 121
A. Korshunov, D. Capper, D. Reuss, D. Schrimpf, M. Ryzhova, V. Hovestadt, D. Sturm, Jochen Meyer, Chris Jones, O. Zheludkova, E. Kumirova, A. Golanov, M. Kool, U. Schüller, M. Mittelbronn, M. Hasselblatt, J. Schittenhelm, G. Reifenberger, C. Herold‐Mende, P. Lichter, A. Deimling, S. Pfister, David Jones (2015)
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entityActa Neuropathologica, 131
Matthew Waitkus, B. Diplas, Hai Yan (2016)
Isocitrate dehydrogenase mutations in gliomas.Neuro-oncology, 18 1
R. Stupp, M. Hegi, W. Mason, M. Bent, M. Taphoorn, R. Janzer, S. Ludwin, A. Allgeier, B. Fisher, K. Bélanger, P. Hau, A. Brandes, J. Gijtenbeek, C. Marosi, C. Vecht, K. Mokhtari, P. Wesseling, S. Villà, E. Eisenhauer, T. Gorlia, M. Weller, D. Lacombe, J. Cairncross, R. Mirimanoff (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.The Lancet. Oncology, 10 5
A. Ebrahimi, M. Skardelly, I. Bonzheim, Ines Ott, H. Mühleisen, F. Eckert, G. Tabatabai, J. Schittenhelm (2016)
ATRX immunostaining predicts IDH and H3F3A status in gliomasActa Neuropathologica Communications, 4
S. Perkins, N. Mitra, W. Fei, E. Shinohara (2012)
Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysisJournal of Neuro-Oncology, 110
J. Chiang, D. Ellison (2017)
Molecular pathology of paediatric central nervous system tumoursThe Journal of Pathology, 241
Chris Jones, S. Baker (2014)
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade gliomaNature Reviews Cancer, 14
F. Rodriguez, T. Tihan, D. Lin, W. McDonald, J. Nigro, B. Feuerstein, Sadhana Jackson, K. Cohen, P. Burger (2014)
Clinicopathologic Features of Pediatric Oligodendrogliomas: A Series of 50 PatientsThe American Journal of Surgical Pathology, 38
D. Sturm, H. Witt, H. Witt, V. Hovestadt, Dong-Anh Khuong-Quang, David Jones, Carolin Konermann, E. Pfaff, M. Tönjes, M. Sill, S. Bender, M. Kool, M. Zapatka, N. Becker, M. Zucknick, T. Hielscher, Xiao-yang Liu, A. Fontebasso, M. Ryzhova, S. Albrecht, K. Jacob, M. Wolter, M. Ebinger, M. Schuhmann, T. Meter, M. Frühwald, H. Hauch, A. Pekrun, B. Radlwimmer, T. Niehues, G. Komorowski, M. Dürken, A. Kulozik, J. Madden, A. Donson, N. Foreman, R. Drissi, M. Fouladi, W. Scheurlen, A. Deimling, A. Deimling, C. Monoranu, W. Roggendorf, C. Herold‐Mende, A. Unterberg, C. Kramm, J. Felsberg, C. Hartmann, B. Wiestler, W. Wick, T. Milde, T. Milde, O. Witt, O. Witt, Anders Lindroth, J. Schwartzentruber, D. Faury, A. Fleming, M. Zakrzewska, P. Liberski, K. Zakrzewski, P. Hauser, M. Garami, Á. Klekner, L. Bognár, Sorana Morrissy, F. Cavalli, Michael Taylor, P. Sluis, J. Koster, R. Versteeg, R. Volckmann, T. Mikkelsen, K. Aldape, G. Reifenberger, V. Collins, J. Majewski, A. Korshunov, P. Lichter, C. Plass, N. Jabado, S. Pfister, S. Pfister (2012)
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.Cancer cell, 22 4
D. Reuss, Yasin Mamatjan, D. Schrimpf, D. Capper, V. Hovestadt, A. Kratz, F. Sahm, C. Koelsche, A. Korshunov, A. Olar, C. Hartmann, J. Reijneveld, P. Wesseling, A. Unterberg, M. Platten, W. Wick, C. Herold‐Mende, K. Aldape, A. Deimling (2015)
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHOActa Neuropathologica, 129
G. Johansson, U. Andersson, B. Melin (2016)
Recent developments in brain tumor predisposing syndromesActa Oncologica, 55
K. Stelzer (2013)
Epidemiology and prognosis of brain metastasesSurgical Neurology International, 4
S. Nobusawa, Takuya Watanabe, P. Kleihues, H. Ohgaki (2009)
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary GlioblastomasClinical Cancer Research, 15
I. Gavrilovic, J. Posner (2005)
Brain metastases: epidemiology and pathophysiologyJournal of Neuro-Oncology, 75
Hai Yan, D. Parsons, Geng-lin Jin, R. McLendon, B. Rasheed, Weishi Yuan, I. Kos, I. Batinic-Haberle, Siân Jones, G. Riggins, H. Friedman, A. Friedman, D. Reardon, J. Herndon, Kenneth Kinzler, V. Velculescu, B. Vogelstein, D. Bigner (2009)
IDH1 and IDH2 mutations in gliomas.The New England journal of medicine, 360 8
H. Ohgaki, Pierre Dessen, B. Jourde, Sonja Horstmann, Tomofumi Nishikawa, P. Patre, C. Burkhard, D. Schüler, N. Probst-Hensch, P. Maiorka, N. Baeza, P. Pisani, Y. Yonekawa, M. Yasargil, U. Lütolf, P. Kleihues (2004)
Genetic Pathways to GlioblastomaCancer Research, 64
Y. Jiao, Patrick Killela, Zachary Reitman, A. Rasheed, C. Heaphy, R. Wilde, F. Rodriguez, S. Rosemberg, S. Oba-Shinjo, S. Marie, C. Bettegowda, N. Agrawal, E. Lipp, Christopher Pirozzi, G. López, Yiping He, H. Friedman, A. Friedman, G. Riggins, M. Holdhoff, P. Burger, R. McLendon, D. Bigner, B. Vogelstein, A. Meeker, K. Kinzler, N. Papadopoulos, L. Diaz, Hai Yan (2012)
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomasOncotarget, 3
J. Eckel-Passow, D. Lachance, A. Molinaro, K. Walsh, P. Decker, H. Sicotte, M. Pekmezci, T. Rice, M. Kosel, I. Smirnov, G. Sarkar, Alissa Caron, T. Kollmeyer, Corinne Praska, A. Chada, C. Halder, H. Hansen, L. McCoy, P. Bracci, Roxanne Marshall, S. Zheng, G. Reis, A. Pico, B. O'neill, J. Buckner, C. Giannini, J. Huse, A. Perry, T. Tihan, M. Berger, Susan Chang, M. Prados, J. Wiemels, J. Wiencke, M. Wrensch, R. Jenkins (2015)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.The New England journal of medicine, 372 26
V. Collins, David Jones, C. Giannini (2015)
Pilocytic astrocytoma: pathology, molecular mechanisms and markersActa Neuropathologica, 129
DN Louis, H Ohgaki, OD Wiestler, WK Cavenee (2016)
WHO classification of Tumours of the central nervous system (revised 4th edition)
B. Kleinschmidt-DeMasters, A. Donson, H. Vogel, N. Foreman (2015)
Pilomyxoid Astrocytoma (PMA) Shows Significant Differences in Gene Expression vs. Pilocytic Astrocytoma (PA) and Variable Tendency Toward Maturation to PABrain Pathology, 25
K. McDonald, T. Tabone, A. Nowak, W. Erber (2015)
Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation.Oncology letters, 9 5
W. Xu, Hui Yang, Ying Liu, Ying Yang, ping wang, Se-Hee Kim, Shinsuke Ito, Chen Yang, Pu Wang, Mengtao Xiao, Lixia Liu, Wenyuan Jiang, Jing Liu, Jinye Zhang, Bin Wang, S. Frye, Yi Zhang, Yanhui Xu, Q. Lei, K. Guan, Shimin Zhao, Y. Xiong (2011)
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.Cancer cell, 19 1
Eli Bar, Alex Lin, T. Tihan, P. Burger, C. Eberhart (2008)
Frequent Gains at Chromosome 7q34 Involving BRAF in Pilocytic AstrocytomaJournal of Neuropathology and Experimental Neurology, 67
J. Barnholtz-Sloan, A. Sloan, F. Davis, F. Vigneau, P. Lai, R. Sawaya (2004)
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 14
N. Shinojima, K. Tada, S. Shiraishi, T. Kamiryo, M. Kochi, Hideo Nakamura, K. Makino, H. Saya, H. Hirano, J. Kuratsu, K. Oka, Y. Ishimaru, Y. Ushio (2003)
Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.Cancer research, 63 20
B Malzkorn, G Reifenberger (2016)
Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016Curr Opin Oncol, 28
H. Takami, A. Yoshida, Shintaro Fukushima, Hideyuki Arita, Y. Matsushita, Taishi Nakamura, M. Ohno, Y. Miyakita, S. Shibui, Y. Narita, K. Ichimura (2015)
Revisiting TP53 Mutations and Immunohistochemistry—A Comparative Study in 157 Diffuse GliomasBrain Pathology, 25
D. Cahill, Kymberly Levine, R. Betensky, P. Codd, Candice Romany, Linsey Reavie, T. Batchelor, P. Futreal, M. Stratton, W. Curry, A. Iafrate, D. Louis (2007)
Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide TreatmentClinical Cancer Research, 13
C. Bettegowda, N. Agrawal, Y. Jiao, M. Sausen, L. Wood, R. Hruban, F. Rodriguez, D. Cahill, R. McLendon, G. Riggins, V. Velculescu, S. Oba-Shinjo, S. Marie, B. Vogelstein, D. Bigner, Hai Yan, N. Papadopoulos, K. Kinzler (2011)
Mutations in CIC and FUBP1 Contribute to Human OligodendrogliomaScience, 333
C. Horbinski (2013)
What do we know about IDH1/2 mutations so far, and how do we use it?Acta Neuropathologica, 125
N. Bush, N. Butowski (2017)
The Effect of Molecular Diagnostics on the Treatment of GliomaCurrent Oncology Reports, 19
D. Solomon, M. Wood, T. Tihan, A. Bollen, N. Gupta, J. Phillips, A. Perry (2016)
Diffuse Midline Gliomas with Histone H3‐K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic AlterationsBrain Pathology, 26
M. Hegi, A. Diserens, T. Gorlia, M. Hamou, N. Tribolet, N. Tribolet, M. Weller, J. Kros, J. Hainfellner, W. Mason, L. Mariani, Jacoline Bromberg, P. Hau, R. Mirimanoff, J. Cairncross, R. Janzer, R. Stupp (2005)
MGMT Gene Silencing and Benefit from Temozolomide in GlioblastomaThe New England Journal of Medicine, 352
Jinghui Zhang, Gang Wu, Claudia Miller, R. Tatevossian, J. Dalton, Bo Tang, Wilda Orisme, C. Punchihewa, Matthew Parker, I. Qaddoumi, F. Boop, Charles Lu, C. Kandoth, L. Ding, Ryan Lee, Robert Huether, Xiang Chen, Erin Hedlund, Panduka Nagahawatte, Michael Rusch, Kristy Boggs, Jinjun Cheng, J. Becksfort, Jing Ma, Guangchun Song, Yongjin Li, Lei Wei, Jianmin Wang, S. Shurtleff, J. Easton, David Zhao, R. Fulton, L. Fulton, D. Dooling, Bhavin Vadodaria, H. Mulder, Chunlao Tang, Kerri Ochoa, C. Mullighan, A. Gajjar, R. Kriwacki, D. Sheer, R. Gilbertson, E. Mardis, R. Wilson, J. Downing, S. Baker, D. Ellison (2013)
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomasNature genetics, 45
A. Olar, K. Wani, Kristin Alfaro-Munoz, L. Heathcock, H. Thuijl, M. Gilbert, T. Armstrong, E. Sulman, D. Cahill, E. Vera‐Bolanos, Ying Yuan, J. Reijneveld, B. Ylstra, P. Wesseling, K. Aldape (2015)
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomasActa Neuropathologica, 129
C. Hartmann, B. Hentschel, M. Simon, M. Westphal, G. Schackert, J. Tonn, M. Loeffler, G. Reifenberger, T. Pietsch, A. Deimling, M. Weller (2013)
Long-Term Survival in Primary Glioblastoma With Versus Without Isocitrate Dehydrogenase MutationsClinical Cancer Research, 19
D. Reuss, F. Sahm, D. Schrimpf, B. Wiestler, D. Capper, C. Koelsche, L. Schweizer, A. Korshunov, David Jones, V. Hovestadt, M. Mittelbronn, J. Schittenhelm, C. Herold‐Mende, A. Unterberg, M. Platten, M. Weller, W. Wick, S. Pfister, A. Deimling (2014)
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastomaActa Neuropathologica, 129
B. Kleinschmidt-DeMasters, D. Aisner, D. Birks, N. Foreman (2013)
Epithelioid GBMs Show a High Percentage of BRAF V600E MutationThe American Journal of Surgical Pathology, 37
E. Ceppa, E. Bouffet, R. Griebel, C. Robinson, T. Tihan (2006)
The Pilomyxoid Astrocytoma and its Relationship to Pilocytic Astrocytoma: Report of a Case and a Critical Review of the EntityJournal of Neuro-Oncology, 81
C. Koelsche, F. Sahm, A. Wöhrer, A. Jeibmann, J. Schittenhelm, P. Kohlhof, M. Preusser, B. Romeike, Hildegard Dohmen-Scheufler, C. Hartmann, M. Mittelbronn, A. Becker, A. Deimling, D. Capper (2014)
BRAF‐Mutated Pleomorphic Xanthoastrocytoma is Associated with Temporal Location, Reticulin Fiber Deposition and CD34 ExpressionBrain Pathology, 24
C. Batista, E. Mariano, B. Barbosa, M. Morgalla, S. Marie, M. Teixeira, G. Lepski (2014)
Adult Neurogenesis and Glial Oncogenesis: When the Process FailsBioMed Research International, 2014
J. Bayliss, P. Mukherjee, Chao-Jing Lu, Siddhant Jain, Chan Chung, D. Martinez, B. Sabari, A. Margol, Pooja Panwalkar, A. Parolia, M. Pekmezci, R. McEachin, M. Cieslik, B. Tamrazi, B. Garcia, G. Rocca, M. Santi, P. Lewis, C. Hawkins, A. Melnick, C. Allis, C. Thompson, A. Chinnaiyan, A. Judkins, S. Venneti (2016)
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomasScience Translational Medicine, 8
M. Weller, K. Kaulich, B. Hentschel, J. Felsberg, D. Gramatzki, T. Pietsch, M. Simon, M. Westphal, G. Schackert, J. Tonn, A. Deimling, T. Davis, W. Weiss, M. Loeffler, G. Reifenberger (2014)
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapyInternational Journal of Cancer, 134
Patrick Killela, Zachary Reitman, Y. Jiao, C. Bettegowda, N. Agrawal, L. Diaz, A. Friedman, H. Friedman, G. Gallia, B. Giovanella, A. Grollman, T. He, Yiping He, R. Hruban, G. Jallo, N. Mandahl, A. Meeker, F. Mertens, G. Netto, B. Rasheed, G. Riggins, T. Rosenquist, M. Schiffman, I. Shih, D. Theodorescu, M. Torbenson, V. Velculescu, Tian-Li Wang, N. Wentzensen, L. Wood, Ming Zhang, R. McLendon, D. Bigner, K. Kinzler, B. Vogelstein, N. Papadopoulos, Hai Yan (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewalProceedings of the National Academy of Sciences, 110
F. Rodriguez, T. Tihan, D. Lin, W. McDonald, J. Nigro, B. Feuerstein, Sadhana Jackson, K. Cohen, P. Burger (2014)
Clinicopathologic Features of Pediatric Oligodendrogliomas
S. Ferris, Benjamin Goode, N. Joseph, C. Kline, David Samuel, N. Gupta, A. Bollen, A. Perry, S. Mueller, D. Solomon (2016)
IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of ageActa Neuropathologica, 132
S. Mack, S. Agnihotri, K. Bertrand, X. Wang, D. Shih, H. Witt, N. Hill, K. Zayne, M. Barszczyk, V. Ramaswamy, M. Remke, Y. Thompson, M. Ryzhova, L. Massimi, W. Grajkowska, B. Lach, N. Gupta, W. Weiss, A. Guha, C. Hawkins, S. Croul, J. Rutka, S. Pfister, A. Korshunov, M. Pekmezci, T. Tihan, Joanna Philips, N. Jabado, G. Zadeh, Michael Taylor (2015)
Spinal Myxopapillary Ependymomas Demonstrate a Warburg PhenotypeClinical Cancer Research, 21
S. Venneti, M. Santi, M. Felicella, D. Yarilin, J. Phillips, L. Sullivan, D. Martinez, A. Perry, P. Lewis, C. Thompson, A. Judkins (2014)
A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomasActa Neuropathologica, 128
G. Robinson, B. Orr, A. Gajjar (2014)
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapyBMC Cancer, 14
K. Chan, J. Han, Dong Fang, Haiyun Gan, Zhiguo Zhang (2013)
A lesson learned from the H3.3K27M mutation found in pediatric gliomaCell Cycle, 12
C. Brennan, R. Verhaak, A. McKenna, B. Campos, H. Noushmehr, S. Salama, Siyuan Zheng, D. Chakravarty, J. Sanborn, Samuel Berman, R. Beroukhim, Brady Bernard, Chang-Jiun Wu, G. Genovese, I. Shmulevich, J. Barnholtz-Sloan, L. Zou, Rahulsimham Vegesna, S. Shukla, G. Ciriello, W. Yung, Wei Zhang, C. Sougnez, T. Mikkelsen, K. Aldape, D. Bigner, Erwin Meir, M. Prados, A. Sloan, K. Black, J. Eschbacher, G. Finocchiaro, W. Friedman, D. Andrews, A. Guha, M. Iacocca, B. O'neill, G. Foltz, J. Myers, D. Weisenberger, R. Penny, R. Kucherlapati, C. Perou, D. Hayes, R. Gibbs, M. Marra, G. Mills, E. Lander, P. Spellman, R. Wilson, C. Sander, J. Weinstein, M. Meyerson, S. Gabriel, P. Laird, D. Haussler, G. Getz, L. Chin (2013)
The Somatic Genomic Landscape of GlioblastomaCell, 155
This article reviews the histologic and molecular characterization of gliomas, including the new “integrated diagnoses” of the World Health Organization Classification, 2016 edition. The entities reviewed within include diffuse gliomas (astrocytoma, oligodendroglioma, glioblastoma), as well as circumscribed and low-grade gliomas (angiocentric glioma, pilocytic astrocytoma, subependymal giant cell astrocytoma, pleomorphic xanthoastrocytoma, pilomyxoid astrocytoma, ependymoma, myxopapillary ependymoma, and subependymoma). Diagnostic, prognostic, and predictive biomarkers are discussed for each entity. We review how molecular testing for IDH1 and ATRX and detection of chromosome 1p/19q codeletion can be used to categorize glioblastomas as IDH-wildtype or IDH-mutant, and lower grade diffuse gliomas into three molecular groups that correlate better with patient outcomes than histologic subtyping. Pediatric diffuse gliomas are highlighted, including diffuse midline glioma, H3 K27M-mutant, and inherited germline mutations that predispose to pediatric gliomas. The utility of genomic profiling of certain gliomas is discussed, including identifying candidates for experimental therapies. This review is meant to be a concise summary of glioma characterization for the practicing pathologist.
Virchows Archiv – Springer Journals
Published: Jul 4, 2017
Access the full text.
Sign up today, get DeepDyve free for 14 days.